Check out the full news segment of Intellia President and CEO, John Leonard, M.D., on @WCVB with @EmilyWCVB discussing how Intellia is investigating #CRISPR in our first clinical trial: https://t.co/YsAgMGV5vg #genomeediting #RoadtotheClinic